2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary

anticoagulants Certification Cardiology Coronary Artery Disease Risk Assessment 03 medical and health sciences 0302 clinical medicine Risk Factors coronary artery revascularization interventions: stents myocardial revasularization Humans acute coronary syndromes Angioplasty, Balloon, Coronary Quality of Health Care ACCF/AHA Practice Guidelines heart diseases Evidence-Based Medicine ultrasound Patient Selection American Heart Association arrhythmias, cardiac United States drug therapy 3. Good health Treatment Outcome Practice Guidelines as Topic Clinical Competence antiplatelet agents coronary angiography platelet aggregation inhibitor Platelet Aggregation Inhibitors
DOI: 10.1161/cir.0b013e31823a5596 Publication Date: 2011-11-08T08:48:14Z
ABSTRACT
Alice K. Jacobs, MD, FACC, FAHA, Chair Jeffrey L. Anderson, MD, FACC, FAHA, Chair-Elect Nancy Albert, PhD, CCNS, CCRN, FAHA Mark A. Creager, MD, FACC, FAHA Steven M. Ettinger, MD, FACC Robert A. Guyton, MD, FACC Jonathan L. Halperin, MD, FACC, FAHA Judith S. Hochman, MD, FACC, FAHA
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (445)
CITATIONS (439)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....